Johnson & Johnson
-
The Johnson & Johnson vaccine promises renewed optimism for widespread distribution
Written by: Parker Davis Edited by: Esther Melamed On Friday, January 29, Johnson & Johnson posted a press release on their website announcing the Phase 3 results of their COVID-19 vaccine candidate. The vaccine, which was developed and produced by Belgian pharmaceutical company Janssen, a subsidiary of Johnson & Johnson, was reported to be 72% effective…
-
Understanding the Impact of SARS-CoV-2 Variants on Vaccination Efficacy
Written by: Sean Brady Edited by: Esther Melamed What does it mean that there are SARS-CoV-2 variants? We have all patiently waited for the COVID-19 vaccines to begin to roll out. As these efforts become actualized, we are unfortunately facing SARS-CoV-2 genetic variants that could potentially undermine vaccination efforts. Before we dive into the impacts of…